Anika Therapeutics, Inc.

Industry

  • Pharmaceuticals
    • Vaccines
    • Specialty Pharmaceuticals
  • Medical Devices
    • Biomaterials
  • Digital Health
    • Disease Management
  • Biotechnology

Other Names/Subsidiaries

  • Anika
  • Fidia Advanced Biopolymers
See more in Biomedtracker

Latest on Anika Therapeutics, Inc.

Pink Sheet

Drug Rebates, Impact On Premiums Must Be Disclosed Under COVID Stimulus Law

 
• By Cathy Kelly

Future US policy debates regarding the connection between prescription drug rebates and insurance costs will be informed by a transparency requirement tucked into the $900bn economic stimulus and US g

Generics Bulletin

Strides Targets $200m-$400m From Injectables

 
• By Vibha Ravi

Strides Pharma Science Ltd. (formerly known as Strides Shasun Ltd. ) has set a revenue target of $200-400m over the next two to four years for the injectables business housed under Stelis Biopharma P

Scrip

Strides Targets $200-400m From Generic Injectables In Mid-Term

 
• By Vibha Ravi

Strides Pharma Science Ltd. (formerly known as Strides Shasun Ltd. ) has set a revenue target of $200-400m over the next two to four years for the injectables business housed under Stelis Biopharma P

Medtech Insight

Market Brief: Global Orthobiologics Market Will Reach $2.3Bn By 2023 With Highest Growth In Cartilage Replacement

 
• By Marion Webb

The global market for orthobiologics for musculoskeletal soft tissue replacement and regeneration is expected to reach $2.3bn by 2023, with a compound annual growth rate (CAGR) of 4.0%, according to "